Please use this identifier to cite or link to this item:
http://hdl.handle.net/10553/121991
DC Field | Value | Language |
---|---|---|
dc.contributor.author | Nathubhai, Amit | en_US |
dc.contributor.author | Haikarainen, Teemu | en_US |
dc.contributor.author | Hayward, Penelope C. | en_US |
dc.contributor.author | Muñoz Descalzo, Silvia | en_US |
dc.contributor.author | Thompson, Andrew S. | en_US |
dc.contributor.author | Lloyd, Matthew D. | en_US |
dc.contributor.author | Lehtiö, Lari | en_US |
dc.contributor.author | Threadgill, Michael D. | en_US |
dc.date.accessioned | 2018-11-25T20:12:09Z | - |
dc.date.accessioned | 2023-04-24T11:54:46Z | - |
dc.date.available | 2018-11-25T20:12:09Z | - |
dc.date.available | 2023-04-24T11:54:46Z | - |
dc.date.issued | 2016 | en_US |
dc.identifier.issn | 0223-5234 | en_US |
dc.identifier.uri | http://hdl.handle.net/10553/52422 | - |
dc.identifier.uri | http://hdl.handle.net/10553/121991 | - |
dc.description.abstract | Tankyrases (TNKSs), members of the PARP (Poly(ADP-ribose)polymerases) superfamily of enzymes, have gained interest as therapeutic drug targets, especially as they are involved in the regulation of Wnt signalling. A series of 2-arylquinazolin-4-ones with varying substituents at the 8-position was synthesised. An 8-methyl group (compared to 8-H, 8-OMe, 8-OH), together with a 4′-hydrophobic or electron-withdrawing group, provided the most potency and selectivity towards TNKSs. Co-crystal structures of selected compounds with TNKS-2 revealed that the protein around the 8-position is more hydrophobic in TNKS-2 compared to PARP-1/2, rationalising the selectivity. The NAD+-binding site contains a hydrophobic cavity which accommodates the 2-aryl group; in TNKS-2, this has a tunnel to the exterior but the cavity is closed in PARP-1. 8-Methyl-2-(4-trifluoromethylphenyl)quinazolin-4-one was identified as a potent and selective inhibitor of TNKSs and Wnt signalling. This compound and analogues could serve as molecular probes to study proliferative signalling and for development of inhibitors of TNKSs as drugs. | en_US |
dc.language | eng | en_US |
dc.relation.ispartof | European Journal of Medicinal Chemistry | en_US |
dc.source | European Journal of Medicinal Chemistry [ISSN 0223-5234], v. 118, p. 316-327, (Agosto 2016) | en_US |
dc.subject | 32 Ciencias médicas | en_US |
dc.subject | 3209 Farmacología | en_US |
dc.subject.other | 2-Arylquinazolin-4-one | en_US |
dc.subject.other | Hydrophobic cavity | en_US |
dc.subject.other | PARP | en_US |
dc.subject.other | Tankyrase | en_US |
dc.subject.other | WNT | en_US |
dc.title | Structure-activity relationships of 2-arylquinazolin-4-ones as highly selective and potent inhibitors of the tankyrases | en_US |
dc.type | info:eu-repo/semantics/article | en_US |
dc.type | Article | en_US |
dc.identifier.doi | 10.1016/j.ejmech.2016.04.041 | en_US |
dc.identifier.pmid | 27163581 | - |
dc.identifier.scopus | 2-s2.0-84965181881 | - |
dc.contributor.orcid | #NODATA# | - |
dc.contributor.orcid | #NODATA# | - |
dc.contributor.orcid | #NODATA# | - |
dc.contributor.orcid | #NODATA# | - |
dc.contributor.orcid | #NODATA# | - |
dc.contributor.orcid | #NODATA# | - |
dc.contributor.orcid | #NODATA# | - |
dc.contributor.orcid | #NODATA# | - |
dc.contributor.authorscopusid | 23976517100 | - |
dc.contributor.authorscopusid | 24721070700 | - |
dc.contributor.authorscopusid | 10142112100 | - |
dc.contributor.authorscopusid | 9235908900 | - |
dc.contributor.authorscopusid | 7404597186 | - |
dc.contributor.authorscopusid | 14620832200 | - |
dc.contributor.authorscopusid | 6507478836 | - |
dc.contributor.authorscopusid | 7007083713 | - |
dc.description.lastpage | 327 | en_US |
dc.description.firstpage | 316 | en_US |
dc.relation.volume | 118 | en_US |
dc.investigacion | Ciencias de la Salud | en_US |
dc.type2 | Artículo | en_US |
dc.identifier.external | 62311698 | - |
dc.description.numberofpages | 13 | en_US |
dc.utils.revision | Sí | en_US |
dc.identifier.ulpgc | No | en_US |
dc.contributor.buulpgc | BU-MED | en_US |
dc.description.sjr | 1,272 | - |
dc.description.jcr | 4,519 | - |
dc.description.sjrq | Q1 | - |
dc.description.jcrq | Q1 | - |
dc.description.scie | SCIE | - |
item.grantfulltext | none | - |
item.fulltext | Sin texto completo | - |
crisitem.author.dept | GIR IUIBS: Diabetes y endocrinología aplicada | - |
crisitem.author.dept | IU de Investigaciones Biomédicas y Sanitarias | - |
crisitem.author.dept | Departamento de Morfología | - |
crisitem.author.orcid | 0000-0003-0939-7721 | - |
crisitem.author.parentorg | IU de Investigaciones Biomédicas y Sanitarias | - |
crisitem.author.fullName | Muñoz Descalzo, Silvia | - |
Appears in Collections: | Artículos |
SCOPUSTM
Citations
25
checked on Nov 17, 2024
WEB OF SCIENCETM
Citations
24
checked on Nov 17, 2024
Page view(s)
98
checked on Nov 16, 2024
Google ScholarTM
Check
Altmetric
Share
Export metadata
Items in accedaCRIS are protected by copyright, with all rights reserved, unless otherwise indicated.